Taking in consideration the neuroprotective properties of caffeine in the brain mediated by A2AR blockade, together with our previous studies, we now hypothesize that caffeine may confer neuroprotection to RGCs in models of glaucoma by controlling the neuroinflammatory response. The gene discussed is ADORA2A; the disease is glaucoma.